Inflammation and metabolic cardiomyopathy
The DOI matches its Crossref record; 115 of the 117 references it cites were found in a registry or an index.
Abstract
Excessive feeding is associated with an increase in the incidence of chronic metabolic diseases, such as obesity, insulin resistance, and type 2 diabetes. Metabolic disturbance induces chronic low-grade inflammation in metabolically-important organs, such as the liver and adipose tissue. Many of the inflammatory signalling pathways are directly triggered by nutrients. The pro-inflammatory mediators in adipocytes and macrophages infiltrating adipose tissue promote both local and systemic pro-inflammatory status. Metabolic cardiomyopathy is a chronic metabolic disease characterized by structural and functional alterations and interstitial fibrosis without coronary artery disease or hypertension. In the early stage of metabolic cardiomyopathy, metabolic disturbance is not accompanied by substantial changes in myocardial structure and cardiac function. However, metabolic disturbance induces subcellular low-grade inflammation in the heart, and in turn, subcellular component abnormalities, such as oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, and impaired calcium handling, leading to impaired myocardial relaxation. In the advanced stage, the vicious cycle of subcellular component abnormalities, inflammatory cell infiltration, and neurohumoral activation induces cardiomyocyte injury and death, and cardiac fibrosis, resulting in impairment of both diastolic and systolic functions. This review discusses some recent advances in understanding involvement of inflammation in metabolic cardiomyopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated macrophages release TNF-α, IL-1b, IL-6, and TGF-β, which stimulate myofibroblasts, increase collagen production, and decrease protease inhibitor secretion [121,122].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [121]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Macrophages are accumulated in the adipose tissue of obese mice and humans.(40,41) Obesity induces a phenotype switch in adipose tissue macrophage polarization from M2 (anti-inflammatory and tissue repairing) state to M1 (in-”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Macrophages are accumulated in the adipose tissue of obese mice and humans.(40,41) Obesity induces a phenotype switch in adipose tissue macrophage polarization from M2 (anti-inflammatory and tissue repairing) state to M1 (in-”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“In contrast, tissue stress or malfunction induces an adaptive response, which is referred to as parainflammation.(58) In the early stage of chronic”
BackgroundRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 1×
“Glucose utilization is reduced by increased fatty acid oxidization via Randle cycle.(24) Insulin is the main anabolic hormone in mammals and is essential for metabolic homeostasis.”
BackgroundEndoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · cited 1×
“ER stress is linked with chronic metabolic diseases, including obesity, insulin resistance, and diabetes.(90) ER stress induces inflammation by activating JNK and/or NF-jB signalling, such as IRE1-mediated activation of JNK, IRE1, and PERK-mediated NF-jB signalling pathway.”
BackgroundA central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“An absence of JNK1 results in decreased adiposity, significantly improves insulin sensitivity and enhances insulin receptor signalling capacity.(33) suppressor of cytokine signalling 3 (SOCS3), protein tyrosine phosphatase-B1 (PTP1B), and JNK inhibit insulin signalling (Figure 2).”
BackgroundFission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 1×
“Mitophagy is closely associated with mitochondrial fission.(109) Since the reduced cardiac autophagy in type1 diabetes is associated with increased Rab9 expression in the mitochon-”
BackgroundNakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · cited 2×
“Oxidized mtDNA into the cytosol during mitochondrial dysfunction may be involved in NLRP3 inflammasome activation (Figure 3).(68,69) Thus, since suppression of autophagy leads to cardiac inflammation via dysfunctional mitochondria, upregulation of autophagy may be a therapeutic target in the advanced stage of metaboli…”
BackgroundThe NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582 · cited 1×
“The link between heart failure and inflammation was first reported in 1990, when circulating levels of TNF were shown to be elevated in severe chronic hearts.(52) In most patients with chronic heart failure, circulating cytokines are elevated and the elevated cytokine levels correlate with the severity of heart failur…”
Background
Cited by
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
“Increased glucotoxicity and lipotoxicity have been associated with immune cell infiltration of target tissues, thereby affecting diabetes-associated target organ damage and cardiovascular complications,(68,69) including the development of metabolic cardiomyopathy.(70,71) Inflammation is a key modulator of metabolic an…”
BackgroundAutophagy and mitophagy in cardiovascular disease
Bravo-San Pedro, J. M., Kroemer, G., & Galluzzi, L. (2017) · Circulation Research · doi:10.1161/circresaha.117.311082 · Cited by 843
Yao, R.-Q., Ren, C., Xia, Z.-F., & Yao, Y.-M. (2021) · Autophagy · doi:10.1080/15548627.2020.1725377 · Cited by 441
“Exerting cytoprotective effects under exposure to atherosclerosis [154]”
BackgroundHong, S.-H., & Choi, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020494 · Cited by 390
“Activated macrophages release TNF-α, IL-1b, IL-6, and TGF-β, which stimulate myofibroblasts, increase collagen production, and decrease protease inhibitor secretion [121,122].”
BackgroundObesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Ren, J., Wu, N. N., Wang, S., Sowers, J. R., & Zhang, Y. (2021) · Physiological Reviews · doi:10.1152/physrev.00030.2020 · Cited by 370
Metadata
- Authors
- Nishida, K., & Otsu, K.
- Corresponding author
- Otsu, Kinya
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-03
- Volume
- 113
- Issue
- 4
- Pages
- 389-398
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W2593856047
- Cited by
- 329
- References
- 117
- Citations by year
- 2026: 22 · 2025: 40 · 2024: 58 · 2023: 45 · 2022: 35 · 2021: 36 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 17
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Heart Foundation (CH/11/3/29051, RG/11/12/29052)
- King’s BHF Centre of Excellence (2E/08/003)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- metabolic cardiomyopathy, low-grade inflammation, myocarditis, obesity, insulin resistance, type 2 diabetes, adipose tissue macrophages, adipocytes, oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, calcium handling, myocardial relaxation, myocardial fibrosis, cardiomyocyte injury, neurohormonal activation, diastolic dysfunction, systolic dysfunction
- MeSH terms
- Animals, Autophagy, Humans, Immunity, Innate, Inflammation, Cardiomyopathies, Myocardium, Prognosis, Signal Transduction, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammation and metabolic cardiomyopathy. https://app.cochat.ai/papers/10.1093/cvr/cvx012
- The paper
- Nishida, K., & Otsu, K. (2017). Inflammation and metabolic cardiomyopathy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvx012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.